November 13th it was announced that VP sales EMEA Stephanie Stenhagen had
purchased 247 shares and participating in the share program for management in
Medistim ASA. The correct number of shares Stephanie Stenhagen purchased under
the management program was 2474 shares at 161,67 per share. After the purchase
she holds 2784 shares. The shares were purchased from Medistim ASA and Medistim
ASA holds 55617 shares after the transaction.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange